Pharmacological agents currently in clinical trials for disorders in neurogastroenterology
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological agents currently in clinical trials for disorders in neurogastroenterology
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 10, Pages 4111-4120
Publisher
American Society for Clinical Investigation
Online
2013-09-30
DOI
10.1172/jci70837
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 848a Lubiprostone Significantly Improves Treatment Response in Non-Methadone Opioid-Induced Bowel Dysfunction Patients with Chronic, Non-Cancer Pain: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2015) M. Mazen Jamal et al. GASTROENTEROLOGY
- 5 Nortriptyline for Idiopathic Gastroparesis: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Trial (NORIG).
- (2015) Henry P. Parkman et al. GASTROENTEROLOGY
- 902 Randomized Placebo-Controlled Trial of Glutamine for the Treatment of Diarrhea-Predominant IBS
- (2015) Sapreet Basra et al. GASTROENTEROLOGY
- 903 TZP-102-Cl-G003 Phase 2B Study Results: Oral TZP-102 Once Daily for 12 Weeks in Patients With Diabetic Gastroparesis
- (2015) Richard W. McCallum et al. GASTROENTEROLOGY
- 900 Efficacy and Safety of Naloxegol in Patients With Opioid-Induced Constipation: Results From 2 Prospective, Randomized, Controlled Trials
- (2015) William D. Chey et al. GASTROENTEROLOGY
- 901 Effect of the H1-Receptor Antagonist Ebastin on Visceral Perception and Clinical Symptoms in IBS
- (2015) Sander van Wanrooij et al. GASTROENTEROLOGY
- 925g Plecanatide, a Novel Guanylate Cyclase-C (GC-C) Receptor Agonist, is Efficacious and Safe in Patients with Chronic Idiopathic Constipation (CIC): Results from a 951 Patient, 12 Week, Multi-Center Trial
- (2015) Philip B. Miner et al. GASTROENTEROLOGY
- 899 Td-1211 Phase 2B Study Demonstrates Increased Bowel Movement Frequency and Constipation-Related Symptom Improvement in Patients With Opioid Induced Constipation (OIC)
- (2015) Ross G. Vickery et al. GASTROENTEROLOGY
- Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation - a comparison in a controlled environment
- (2013) R. Cinca et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE)
- (2013) Evan S Dellon et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome
- (2013) Michael Camilleri EXPERT OPINION ON PHARMACOTHERAPY
- The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity
- (2013) Scott R. Armstrong et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Effect of hyoscine butylbromide (Buscopan®) on cholinergic pathways in the human intestine
- (2013) D. Krueger et al. NEUROGASTROENTEROLOGY AND MOTILITY
- FDA and EMA end points: which outcome end points should we use in clinical trials in patients with irritable bowel syndrome?
- (2013) M. Corsetti et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain
- (2013) Anne Lund Krarup et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers
- (2012) W. O. Rohof et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mechanisms of Reflux Perception in Gastroesophageal Reflux Disease: A Review
- (2012) Albert J Bredenoord AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical Guideline: Management of Gastroparesis
- (2012) Michael Camilleri et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome
- (2012) Michael Camilleri et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome
- (2012) Michael Camilleri et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists
- (2012) J Broad et al. BRITISH JOURNAL OF PHARMACOLOGY
- Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists
- (2012) G J Sanger et al. BRITISH JOURNAL OF PHARMACOLOGY
- Methadone but not Morphine Inhibits Lubiprostone-Stimulated Cl− Currents in T84 Intestinal Cells and Recombinant Human ClC-2, but not CFTR Cl− Currents
- (2012) John Cuppoletti et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Efficacy of Buspirone, a Fundus-Relaxing Drug, in Patients With Functional Dyspepsia
- (2012) Jan Tack et al. Clinical Gastroenterology and Hepatology
- Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea
- (2012) Banny S. Wong et al. Clinical Gastroenterology and Hepatology
- Evolving Molecular Targets in the Treatment of Nonmalignant Gastrointestinal Diseases
- (2012) D A Katzka et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Randomized Controlled Phase Ib Study of Ghrelin Agonist, RM-131, in Type 2 Diabetic Women With Delayed Gastric Emptying: Pharmacokinetics and pharmacodynamics
- (2012) A. Shin et al. DIABETES CARE
- Effect of Mosapride Combined with Esomeprazole Improves Esophageal Peristaltic Function in Patients with Gastroesophageal Reflux Disease: A Study Using High Resolution Manometry
- (2012) Yu Kyung Cho et al. DIGESTIVE DISEASES AND SCIENCES
- Activation of Colonic Mucosal 5-HT4 Receptors Accelerates Propulsive Motility and Inhibits Visceral Hypersensitivity
- (2012) Jill M. Hoffman et al. GASTROENTEROLOGY
- Measurement of Spleen Stiffness by Acoustic Radiation Force Impulse Imaging Identifies Cirrhotic Patients With Esophageal Varices
- (2012) Yoshitaka Takuma et al. GASTROENTEROLOGY
- A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis
- (2012) N. Ejskjaer et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography
- (2012) H. Kusunoki et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome
- (2012) H. Duboc et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome – a pilot study
- (2012) Ashok K. Tuteja et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial
- (2012) Yasushi Fukushima et al. Journal of Neurogastroenterology and Motility
- Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting - randomised clinical study subset data
- (2011) J. M. Wo et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study
- (2011) J. F. Tack et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the treatment of noncardiac chest pain
- (2011) T. Hershcovici et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome
- (2011) P. Clavé et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome
- (2011) C. N. Andrews et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
- (2011) Michael Camilleri AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Females With Functional Constipation
- (2011) Banny S Wong et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
- (2011) Stacy B Menees et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
- (2011) William D Chey et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome
- (2011) M Camilleri CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Tryptophan Hydroxylase Inhibitor LX1031 Shows Clinical Benefit in Patients With Nonconstipating Irritable Bowel Syndrome
- (2011) Philip M. Brown et al. GASTROENTEROLOGY
- Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation
- (2011) Sara Nullens et al. GUT
- A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
- (2011) Kei Matsueda et al. GUT
- A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/012) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain
- (2011) Jan-Peter Jansen et al. JOURNAL OF PAIN
- A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/013) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain
- (2011) Gordon Irving et al. JOURNAL OF PAIN
- GSK962040: a small molecule motilin receptor agonist which increases gastrointestinal motility in conscious dogs
- (2011) S. Leming et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine
- (2011) K. J. Lee et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
- (2011) Mark Pimentel et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Evaluation of Otilonium Bromide Treatment in Asian Patients With Irritable Bowel Syndrome
- (2011) Full-Young Chang et al. Journal of Neurogastroenterology and Motility
- Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study
- (2010) M. Goldberg et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Comparison of selective M3 and nonselective muscarinic receptor antagonists on gastrointestinal transit and bowel habits in humans
- (2010) Adil E. Bharucha et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Overall Mortality, Incremental Life Expectancy, and Cause of Death at 25 Years in the Program on the Surgical Control of the Hyperlipidemias
- (2010) Henry Buchwald et al. ANNALS OF SURGERY
- Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee
- (2010) Marc Afilalo et al. CLINICAL DRUG INVESTIGATION
- Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
- (2010) Keith A. Candiotti et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation
- (2010) Cornelius E. J. Sloots et al. DIGESTIVE DISEASES AND SCIENCES
- Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
- (2010) Robert Buynak et al. EXPERT OPINION ON PHARMACOTHERAPY
- The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome
- (2010) T. K. Klooker et al. GUT
- Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain
- (2010) A. Sandner-Kiesling et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- 5-HT4 receptor agonists: similar but not the same
- (2010) J. H. De Maeyer et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study
- (2010) N. Ejskjaer et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis
- (2009) N. EJSKJAER et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study
- (2009) R. CORINALDESI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome
- (2009) L. WEDLAKE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of the 5-HT1A Agonist Tandospirone Citrate in Improving Symptoms of Patients With Functional Dyspepsia: A Randomized Controlled Trial
- (2009) Hiroto Miwa et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Epidemiology of Eosinophilic Esophagitis Over Three Decades in Olmsted County, Minnesota
- (2009) Ganapathy A. Prasad et al. Clinical Gastroenterology and Hepatology
- 156 Clinical Benefit in IBS After Disodium Cromoglycate Involves Mast Cell-Mediated Recovery of Healthy-Like Innate Immunity Genes Expression Profile in the Jejunal Mucosa
- (2009) Beatriz Lobo et al. GASTROENTEROLOGY
- Reducing the Gastrointestinal Risks of Low-Dose Aspirin
- (2009) Byron Cryer GASTROENTEROLOGY
- Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man
- (2009) d. ang et al. NEUROGASTROENTEROLOGY AND MOTILITY
- A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia
- (2009) j. tack et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Differential effects of transient receptor vanilloid one (TRPV1) antagonists in acid-induced excitation of esophageal vagal afferent fibers of rats
- (2009) S. Peles et al. NEUROSCIENCE
- Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia
- (2008) N. J. TALLEY et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome
- (2008) A. W. MANGEL et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
- (2008) P. M. HELLSTRÖM et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome
- (2008) K. Matsueda et al. DIGESTION
- A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation
- (2008) Winfried Meissner et al. EUROPEAN JOURNAL OF PAIN
- Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain
- (2008) Dana Vondrackova et al. JOURNAL OF PAIN
- Effects of serotonin 5-HT3receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer
- (2008) t. hirata et al. NEUROGASTROENTEROLOGY AND MOTILITY
- A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation
- (2008) Michael Camilleri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
- (2008) Lynn Webster et al. PAIN
- A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome
- (2008) Kei Matsueda et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started